-
Product Insights
Vitiligo - Drugs In Development, 2024
Empower your strategies with our Vitiligo – Drugs In Development, 2024 report and make more profitable business decisions. Vitiligo is a condition in which skin loses melanin, the pigment that determines the color of skin, hair, and eyes. Symptoms include premature whitening or graying of the hair on teh scalp, eyelashes, eyebrows, or beard; loss of color in the tissues that line the inside of mouth; and loss of or change in color of the inner layer of eye. Treatment includes...
-
Sector Analysis
Vitiligo Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Vitiligo Marketed and Pipeline Drugs Report Overview Vitiligo is a skin condition characterized by the loss of pigment from certain areas of the skin, resulting in irregular white patches that appear normal in texture. The condition arises when immune cells attack and destroy melanocytes, the cells responsible for producing the brown pigment in the skin. Approximately 34 million diagnosed prevalent cases of vitiligo are anticipated in 2024 in the 16 major pharmaceutical markets. In 2024, India is expected to have...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.